LINDSEY PEARISON: Open Payments
NPI 1033936133 · NEWBURGH, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$436 in 16 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $17 · 2025 $436
Food & beverage: $436
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 4 | $111 |
| Novo Nordisk Inc | 2 | $97 |
| Biogen, Inc. | 3 | $71 |
| Hologic Sales and Service, LLC | 2 | $44 |
| Ethicon US, LLC | 1 | $41 |
| MAYNE PHARMA COMMERCIAL LLC | 2 | $37 |
| Sumitomo Pharma America, Inc. | 1 | $21 |
| Exact Sciences Corporation | 1 | $14 |
Products named: Veozah, ZURZUVAE, STRATAFIX, Sonata Sonography-Guided Transcervical Fibroid Ablation System, MYFEMBREE, Wegovy, Cologuard Collection Kit, NOVASURE.
Industry payments across IN — which companies pay providers there.
